BioNTech Sp ADS
BNTX
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
04/22/2025 - 02:00:00
Bid
04/22/2025 - 14:38:48
Bid
Volume
Ask
04/22/2025 - 14:38:48
Ask
Volume
101.81
+3.05 ( +3.09% )
100.94
200
101.25
200
More information
Analysis by TheScreener
18.04.2025
Evaluation Slightly negative  
Interest Very weak  
Sensibility High  
Analysis date: 18.04.2025
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 18.04.2025.
Interest
  Very weak
One star since 11.04.2025.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 11.03.2025 at a price of 98.39.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
  Negative
 
The forty day technical trend is negative since 25.02.2025.
4wk Rel Perf
  5.71%
 
The four-week dividend-adjusted overperformance versus SP500 is 5.71%.
Sensibility
  High
The stock has been on the high-sensitivity level since 07.02.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.26%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.58%.
Mkt Cap in $bn
  23.70
With a market capitalization >$8bn, BIONTECH SE is considered a large-cap stock.
G/PE Ratio
  -0.88
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
  -22.37
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
  -19.58%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  19
Over the last seven weeks, an average of 19 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  94
For 1% of index variation, the stock varies on average by 0.94%.
Correlation
  0.37
Stock movements are strongly independent of index variations.
Value at Risk
  33.07
The value at risk is estimated at USD 33.07. The risk is therefore 33.49%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  02.07.2021